American Journal of Epidemiology Vol. 141, No. 3: 198-209
Copyright © 1995 by The Johns Hopkins University School of Hygiene and Public Health
research-article |
Ingested Arsenic and Internal Cancer: A Historical Cohort Study Followed for 33 Years
1Department of Hygiene and Preventive Medicine, Okayama University Medical School 2-5-1 Shikata-cho, Okayama 700, Japan
2Department of Applied Mathematics, Okayama University of Science 1-1 Ridal-cho, Okayama 700, Japan
3Department of Public Health, Nara Medical University 480 Shijou-cho, Kashihara 634, Japan
Department of Hygiene and Preventive Medicine, Okayama University Medical School, 2-5-1 Shikata-cho, Okayama 700, Japan. Reprint requests to Dr. Toshihide Tsuda at this address
A historical cohort study was conducted to investigate the long-term effect of exposure to ingested arsenic. The 454 residents who had been identified in a list made in 1959 were followed until 1992. They lived in an arsenic-polluted area, called Namiki-cho, Nakajo-machi, in Niigata Prefecture, Japan, and used well water containing inorganic arsenic. The exposure period was estimated to be about 5 years (1955–1959). Death certificates for the people who died between 1959 and 1992 were examined, and a total of 113 of the 454 residents were estimated to have drunk well water containing a high dose of arsenic (
1 ppm). The standardized mortality rate ratios of these 113 residents were 15.69 for lung cancer (observed/expected = 8/0.51; 95% confidence interval (CI) 7.38–31.02) and 31.18 for urinary tract cancer (observed/expected = 3/0.10; 95% CI 8.62–91.75). Cox's proportional hazard analyses demonstrated that the hazard ratios of the highest exposure level group (1 ppm) versus the background exposure level group (0.001 ppm) were 1.74 (95% CI 1.10–2.74) for all deaths and 4.82 (95% CI 2.09–11.14) for all cancers. The analysis according to the skin signs of chronic arsenicism in 1959 showed that they were useful risk indicators for subsequent cancer development. In the development of lung cancer, there was evidence of synergism between arsenic intake and smoking habit.
arsenic; bladder neoplasms; lung neopiasms; skin manifestations; smoking
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  S. Somji, X. D. Zhou, S. H. Garrett, M. A. Sens, and D. A. Sens Urothelial Cells Malignantly Transformed by Exposure to Cadmium (Cd+2) and Arsenite (As+3) Have Increased Resistance to Cd+2 and As+3-Induced Cell Death Toxicol. Sci., December 1, 2006; 94(2): 293 - 301. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Ding, J. Li, C. Xue, K. Wu, W. Ouyang, D. Zhang, Y. Yan, and C. Huang Cyclooxygenase-2 Induction by Arsenite Is through a Nuclear Factor of Activated T-cell-dependent Pathway and Plays an Antiapoptotic Role in Beas-2B Cells J. Biol. Chem., August 25, 2006; 281(34): 24405 - 24413. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 O. S. von Ehrenstein, D. N. Guha Mazumder, M. Hira-Smith, N. Ghosh, Y. Yuan, G. Windham, A. Ghosh, R. Haque, S. Lahiri, D. Kalman, et al. Pregnancy Outcomes, Infant Mortality, and Arsenic in Drinking Water in West Bengal, India Am. J. Epidemiol., April 1, 2006; 163(7): 662 - 669. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. K. Sharma, J. C. Tjell, and H. Mosbaek Health effects from arsenic in groundwater of the Bengal delta: Effects of iron and water storage practices Environmental Geosciences, March 1, 2006; 13(1): 17 - 29. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. P. Waalkes, J. Liu, J. M. Ward, D. A. Powell, and B. A. Diwan Urogenital Carcinogenesis in Female CD1 Mice Induced by In utero Arsenic Exposure Is Exacerbated by Postnatal Diethylstilbestrol Treatment Cancer Res., February 1, 2006; 66(3): 1337 - 1345. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
O. S. von Ehrenstein, D. N. G. Mazumder, Y. Yuan, S. Samanta, J. Balmes, A. Sil, N. Ghosh, M. Hira-Smith, R. Haque, R. Purushothamam, et al. Decrements in Lung Function Related to Arsenic in Drinking Water in West Bengal, India Am. J. Epidemiol., September 15, 2005; 162(6): 533 - 541. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. A. Rodriguez-Gabriel and P. Russell Distinct Signaling Pathways Respond to Arsenite and Reactive Oxygen Species in Schizosaccharomyces pombe Eukaryot. Cell, August 1, 2005; 4(8): 1396 - 1402. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. M. Zierold, L. Knobeloch, and H. Anderson Prevalence of Chronic Diseases in Adults Exposed to Arsenic-Contaminated Drinking Water Am J Public Health, November 1, 2004; 94(11): 1936 - 1937. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. S. Michaud, M. E. Wright, K. P. Cantor, P. R. Taylor, J. Virtamo, and D. Albanes Arsenic Concentrations in Prediagnostic Toenails and the Risk of Bladder Cancer in a Cohort Study of Male Smokers Am. J. Epidemiol., November 1, 2004; 160(9): 853 - 859. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. E. Beane Freeman, L. K. Dennis, C. F. Lynch, P. S. Thorne, and C. L. Just Toenail Arsenic Content and Cutaneous Melanoma in Iowa Am. J. Epidemiol., October 1, 2004; 160(7): 679 - 687. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. A. Sens, S. Park, V. Gurel, M. A. Sens, S. H. Garrett, and S. Somji Inorganic Cadmium- and Arsenite-Induced Malignant Transformation of Human Bladder Urothelial Cells Toxicol. Sci., May 1, 2004; 79(1): 56 - 63. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H.-R. Guo, N.-S. Wang, H. Hu, and R. R. Monson Cell Type Specificity of Lung Cancer Associated with Arsenic Ingestion Cancer Epidemiol. Biomarkers Prev., April 1, 2004; 13(4): 638 - 643. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C.D. Evans, K. LaDow, B.L. Schumann, R.E. Savage Jr, J. Caruso, A. Vonderheide, P. Succop, and G. Talaska Effect of arsenic on benzo[a]pyrene DNA adduct levels in mouse skin and lung Carcinogenesis, April 1, 2004; 25(4): 493 - 497. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. Danaee, H. H. Nelson, H. Liber, J. B. Little, and K. T. Kelsey Low dose exposure to sodium arsenite synergistically interacts with UV radiation to induce mutations and alter DNA repair in human cells Mutagenesis, March 1, 2004; 19(2): 143 - 148. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Steinmaus, Y. Yuan, M. N. Bates, and A. H. Smith Case-Control Study of Bladder Cancer and Drinking Water Arsenic in the Western United States Am. J. Epidemiol., December 15, 2003; 158(12): 1193 - 1201. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. O. Abernathy, D. J. Thomas, and R. L. Calderon Health Effects and Risk Assessment of Arsenic J. Nutr., May 1, 2003; 133(5): 1536S - 1538. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. P. Simeonova, S. Wang, M. L. Kashon, C. Kommineni, E. Crecelius, and M. I. Luster Quantitative Relationship between Arsenic Exposure and AP-1 Activity in Mouse Urinary Bladder Epithelium Toxicol. Sci., April 1, 2001; 60(2): 279 - 284. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H.-Y. Chiou, S.-T. Chiou, Y.-H. Hsu, Y.-L. Chou, C.-H. Tseng, M.-L. Wei, and C.-J. Chen Incidence of Transitional Cell Carcinoma and Arsenic in Drinking Water: A Follow-up Study of 8,102 Residents in an Arseniasis-endemic Area in Northeastern Taiwan Am. J. Epidemiol., March 1, 2001; 153(5): 411 - 418. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. P. Simeonova, S. Wang, W. Toriuma, V. Kommineni, J. Matheson, N. Unimye, F. Kayama, D. Harki, M. Ding, V. Vallyathan, et al. Arsenic Mediates Cell Proliferation and Gene Expression in the Bladder Epithelium: Association with Activating Protein-1 Transactivation Cancer Res., July 1, 2000; 60(13): 3445 - 3453. [Abstract] [Full Text]
|
|